> > Education for You

> > Education for You

Educational materials to help you live with a bleeding disorder.

Novo Nordisk believes in supporting you by providing educational materials and tools that help you manage a bleeding disorder.

  • Hemophilia with Inhibitors

    This brochure helps people with hemophilia A or B with inhibitors understand hemophilia and inhibitors and highlights the reasons why NovoSeven® RT may be right for you.

    Download

  • Factor VII Deficiency

    This brochure is designed for people with factor VII deficiency. It covers the basics of this condition, signs and symptoms, available treatments, and more.

    Download

  • Glanzmann’s Thrombasthenia

    This brochure provides in-depth information about Glanzmann’s thrombasthenia with resistance to platelets, and the effectiveness of NovoSeven® RT in treating this condition.

    Download

  • Hemophilia Dictionary

    This handy reference defines common terms used when talking about various bleeding disorders, with statistics and other facts that may help increase your understanding and awareness.

    Download

Patient advocacy groups.

Materials available through a Novo Nordisk Hemophilia Community Liaison (HCL):

The following items are available by contacting a Novo Nordisk HCL:

MixPro® Demonstration Kit NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

MixPro® Demonstration Kit

With this kit, you can learn how quick it is to reconstitute a dose of NovoSeven® RT, and get an idea of its compact storage size and portability.

Patient Starter Kit NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

Starter Kit

Practice mixing a dose before you start treatment. This kit includes a sample device, bilingual (English/Spanish) step by step instructions, introductory brochure, and Web key with an instructional reconstitution video.

Ready-to-Travel Case for NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

Ready-to-Travel Case

This portable, reusable travel case makes storing supplies easy, at home or while traveling.

To order any of these items, please contact a Novo Nordisk HCL.

Selected Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT

What is NovoSeven® RT?

NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for:

  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia

Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT
  • You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness

What should I tell my healthcare provider before using NovoSeven® RT?

  • Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots:
    • congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates)
    • are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding
    • history of heart or blood vessel diseases
  • Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies

What are the possible side effects of NovoSeven® RT?

  • The most common and serious side effects are blood clots
  • Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction

Please click here for Prescribing Information